1. Home
  2. KTTA vs BWBBP Comparison

KTTA vs BWBBP Comparison

Compare KTTA & BWBBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$0.57

Market Cap

18.1M

Sector

Health Care

ML Signal

HOLD

Logo Bridgewater Bancshares Inc.

BWBBP

Bridgewater Bancshares Inc.

N/A

Current Price

$19.79

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
KTTA
BWBBP
Founded
2020
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
18.1M
N/A
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
KTTA
BWBBP
Price
$0.57
$19.79
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
182.5K
2.6K
Earning Date
05-14-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
77.07
44.66
EPS
N/A
1.03
Revenue
$486,559.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$19.24
Revenue Growth
3130.37
N/A
52 Week Low
$0.28
$18.76
52 Week High
$2.06
$22.48

Technical Indicators

Market Signals
Indicator
KTTA
BWBBP
Relative Strength Index (RSI) 56.49 46.47
Support Level $0.54 $19.55
Resistance Level $0.61 $20.56
Average True Range (ATR) 0.04 0.08
MACD 0.00 0.00
Stochastic Oscillator 70.91 55.12

Price Performance

Historical Comparison
KTTA
BWBBP

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

About BWBBP Bridgewater Bancshares Inc.

Bridgewater Bancshares Inc is a financial holding company. Through its subsidiary, it offers various personal and commercial banking products and services such as savings accounts, certificates of deposits, money transfer services, digital wallets, credit and debit cards, safe deposit lockers, different types of loans and advances, commercial deposit accounts, treasury management, and others. The company principally focuses on catering to commercial clients, offering a suite of loan and deposit products. Geographically, it mainly operates in the Twin Cities Metropolitan Statistical Area in the United States.

Share on Social Networks: